[Use of phthivazide in the treatment of patients with acute pneumonia and chronic bronchitis].
The treatment scheme of 540 patients with acute pneumonia and chronic bronchitis involved a 0.5 g ftivazid three times a day for 15-20 days. Compared with control groups of patients on the standard therapy, the drug presents a more advantageous treatment. Adequate efficacy and tolerance of the drug ftivazid make it appropriate for use in acute pneumonia and chronic bronchitis.
V Ia
VIa
Garmash
S S
SS
Iakushin
O V
OV
Kolobaeva
V A
VA
Romanov
D000208:Acute Disease; D000894:Anti-Inflammatory Agents, Non-Steroidal; D001991:Bronchitis / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D011014:Pneumonia / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007538:Isoniazid
Ispol'zovanie ftivazida v lechenii bol'nykh ostroĭ pnevmonieĭ i khronicheskim bronkhitom.